Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.humimm.2009.06.013
DC FieldValue
dc.titleIFIH1 gene polymorphisms in type 1 diabetes: Genetic association analysis and genotype-phenotype correlation in the Belgian population
dc.contributor.authorAminkeng, Folefac
dc.contributor.authorVan Autreve, Jan E
dc.contributor.authorWeets, Ilse
dc.contributor.authorQuartier, Erik
dc.contributor.authorVan Schravendijk, Chris
dc.contributor.authorGorus, Frans K
dc.contributor.authorVan der Auwera, Bart J
dc.date.accessioned2022-12-05T03:46:51Z
dc.date.available2022-12-05T03:46:51Z
dc.date.issued2009-09-01
dc.identifier.citationAminkeng, Folefac, Van Autreve, Jan E, Weets, Ilse, Quartier, Erik, Van Schravendijk, Chris, Gorus, Frans K, Van der Auwera, Bart J (2009-09-01). IFIH1 gene polymorphisms in type 1 diabetes: Genetic association analysis and genotype-phenotype correlation in the Belgian population. HUMAN IMMUNOLOGY 70 (9) : 706-710. ScholarBank@NUS Repository. https://doi.org/10.1016/j.humimm.2009.06.013
dc.identifier.issn0198-8859
dc.identifier.issn1879-1166
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/235314
dc.description.abstractThe evaluation of susceptibility loci in a registry-based setting could be an important addition to the current predictive and screening models in T1D. Therefore, the aim of this study was to evaluate the importance of one of these loci, IFIH1. T1D patients (n=1981), control subjects (n=2092) and 430 families were genotyped for HLA-DQ and IFIH1 nsSNP rs1990760 (Ala946Thr). In the association analysis, the allelic frequencies, A (62.4% vs. 61.3%) and G (37.6% vs. 38.7%) were similar in cases and controls (χ2 = 0.98, p = 0.32), the genotypic frequencies reveals a weak association with T1D (χ2 = 6.79, p = 0.03), no significant transmission distortions in families (%T; A = 51.4%, G = 48.0 %, χ2 = 1.76, p = 0.19) and no interaction with HLA-DQ-linked risk. Furthermore, no genotype-phenotype correlation was observed. In conclusion, IFIH1 has no important role in T1D risk assessment in a registry-based Belgian population. © 2009 American Society for Histocompatibility and Immunogenetics.
dc.language.isoen
dc.publisherELSEVIER SCIENCE INC
dc.sourceElements
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectImmunology
dc.subjectType 1 diabetes
dc.subjectGenetic association
dc.subjectInterferon-induced helicase
dc.subjectIFIH1
dc.subjectAutoimmune disease
dc.subjectGENOME-WIDE ASSOCIATION
dc.subjectIFIH1-GCA-KCNH7 LOCUS
dc.subjectMULTIPLE-SCLEROSIS
dc.subjectA946T POLYMORPHISM
dc.subjectGRAVES-DISEASE
dc.subjectSUSCEPTIBILITY
dc.subjectRISK
dc.subjectAGE
dc.typeArticle
dc.date.updated2022-11-30T19:51:07Z
dc.contributor.departmentMEDICINE
dc.description.doi10.1016/j.humimm.2009.06.013
dc.description.sourcetitleHUMAN IMMUNOLOGY
dc.description.volume70
dc.description.issue9
dc.description.page706-710
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
1-s2.0-S0198885909001591-main.pdf252.31 kBAdobe PDF

CLOSED

Published

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.